Adial Pharmaceuticals, Inc. - Common Stock (ADIL)

CUSIP: 00688A205

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
5,493,768
Total 13F shares
289,676
Share change
+94,686
Total reported value
$292,303
Price per share
$1.01
Number of holders
13
Value change
+$95,706
Number of buys
6
Number of sells
4

Security key

00688A205

Report period

Q4 2024

Institutions

13

Top holders

10

Ownership snapshot

Top shareholders of ADIL - Adial Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Manchester Capital Manage...
13D/G signal
Evidence rows
14
Latest as of
30 Sep 2024
13F 3/4/5 Lead comparable stake: 0.88% Showing first 8 of 14 holder rows. Open remaining rows
Holder Evidence Ownership % Position 12M Net Δ As of
Manchester Capital Management LLC
13F
Company
13F
0.88%
$48,049
48,097 shares
30 Sep 2024
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.83%
$45,420
45,466 shares
30 Sep 2024
CITADEL ADVISORS LLC
13F
Company
13F
0.61%
$33,237
33,270 shares
30 Sep 2024
BlackRock, Inc.
13F
Company
13F
0.51%
$27,742
27,770 shares
30 Sep 2024
TWO SIGMA SECURITIES, LLC
13F
Company
13F
0.49%
$27,088
27,115 shares
30 Sep 2024
UBS Group AG
13F
Company
13F
0.08%
$4,400
4,404 shares
30 Sep 2024
Tower Research Capital LLC (TRC)
13F
Company
13F
0.07%
$3,939
3,943 shares
30 Sep 2024
1620 INVESTMENT ADVISORS, INC.
13F
Company
13F
0.07%
$3,596
3,600 shares
30 Sep 2024
Show 6 additional holder rows in the full holder list
Holder Evidence Ownership % Position 12M Net Δ As of
MORGAN STANLEY
13F
Company
13F
0.01%
$309
309 shares
30 Sep 2024
BANK OF AMERICA CORP /DE/
13F
Company
13F
0%
$52
52 shares
30 Sep 2024
Abound Wealth Management
13F
Company
13F
0%
$27
27 shares
30 Sep 2024
William B. Stilley III
3/4/5
Director
mixed-class rows
$530,200
1,311,779 shares
mixed-class rows
23 May 2023
Joseph Truluck
3/4/5
Chief Financial Officer
mixed-class rows
$111,411
290,139 shares
mixed-class rows
25 Mar 2024
Dr. Bankole Johnson
3/4/5
Director
class O/S missing
40,000 shares
23 May 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
13
Shares
289,676
Rows loaded
13
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. An asterisk next to the price means the price is likely invalid.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
11
Q4 2024 holders
13
Holder diff
2
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .